NM_052867.4:c.2520C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_052867.4(NALCN):c.2520C>T(p.Val840Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00888 in 1,614,104 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0084 ( 104 hom. )
Consequence
NALCN
NM_052867.4 synonymous
NM_052867.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.372
Publications
4 publications found
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
- congenital contractures of the limbs and face, hypotonia, and developmental delayInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- hypotonia, infantile, with psychomotor retardation and characteristic facies 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- digitotalar dysmorphismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Freeman-Sheldon syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Sheldon-hall syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypotonia, infantile, with psychomotor retardation and characteristic faciesInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- temporal lobe epilepsyInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 13-101107546-G-A is Benign according to our data. Variant chr13-101107546-G-A is described in ClinVar as [Benign]. Clinvar id is 262257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.372 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0132 (2015/152300) while in subpopulation AFR AF = 0.0272 (1130/41562). AF 95% confidence interval is 0.0259. There are 20 homozygotes in GnomAd4. There are 951 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NALCN | NM_052867.4 | c.2520C>T | p.Val840Val | synonymous_variant | Exon 22 of 44 | ENST00000251127.11 | NP_443099.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0132 AC: 2015AN: 152182Hom.: 21 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2015
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00879 AC: 2208AN: 251220 AF XY: 0.00880 show subpopulations
GnomAD2 exomes
AF:
AC:
2208
AN:
251220
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00842 AC: 12314AN: 1461804Hom.: 104 Cov.: 31 AF XY: 0.00867 AC XY: 6302AN XY: 727202 show subpopulations
GnomAD4 exome
AF:
AC:
12314
AN:
1461804
Hom.:
Cov.:
31
AF XY:
AC XY:
6302
AN XY:
727202
show subpopulations
African (AFR)
AF:
AC:
908
AN:
33478
American (AMR)
AF:
AC:
267
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
560
AN:
26132
East Asian (EAS)
AF:
AC:
2
AN:
39694
South Asian (SAS)
AF:
AC:
861
AN:
86258
European-Finnish (FIN)
AF:
AC:
37
AN:
53414
Middle Eastern (MID)
AF:
AC:
117
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
8970
AN:
1111960
Other (OTH)
AF:
AC:
592
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
727
1454
2180
2907
3634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0132 AC: 2015AN: 152300Hom.: 20 Cov.: 33 AF XY: 0.0128 AC XY: 951AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
2015
AN:
152300
Hom.:
Cov.:
33
AF XY:
AC XY:
951
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
1130
AN:
41562
American (AMR)
AF:
AC:
153
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
63
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5184
South Asian (SAS)
AF:
AC:
45
AN:
4822
European-Finnish (FIN)
AF:
AC:
2
AN:
10614
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
570
AN:
68022
Other (OTH)
AF:
AC:
19
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
103
206
310
413
516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.